Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector

Weight-loss treatments are not the only source of excitement in the pharmaceutical research world

Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues

Employees are being offered the ‘party drug’ through company health schemes as psychedelic-assisted therapy grows in popularity

For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value

Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’